Skip to main content

Table 7 Categories and subcategories of cancer drugs considered for analysis

From: Off-label use of cancer therapies in women diagnosed with breast cancer in the United States

Category Subcategory
Chemotherapies Alkylating agents, Antimetabolites, Anti-tumor antibiotics, Topoisomerase inhibitors, Anti-mitotic agents
Hormone therapies Estrogen receptor modulators, Aromatase inhibitors, anti-Androgens
Targeted thrapies Small-molecule inhibitors, Differentiating agents
Immunootherapies Monoclonal antibodies, Non-specific Immunotherapies andadjuvants, Immunomodulators
  1. All therapies in these categories and subcategories that were FDA-approved for a cancer indication during the study period were evaluated.